The Protecting Access to Medicare Act of 2014 (PAMA) significantly revised the Medicare payment system for clinical diagnostic laboratory tests by requiring that payment rates under the Clinical Laboratory Fee Schedule (CLFS) be based on the weighted median of private payor rates, along with other related provisions.
Certain laboratories that meet criteria established by the Centers for Medicare & Medicaid Services (see more below) are required to report Healthcare Common Procedure Coding System (HCPCS) laboratory codes, associated private payor rates, and volume data.
Find out if your lab is considered "applicable."
Importantly, labs that did not report in 2017 may now be required to report. Do not rely on whether your lab reported in 2017 or not.
Note: CMS is sending a letter by mail to entities that it believes are applicable laboratories. However, keep in mind that it may have outdated contact information and the letter may not reach the right person.
In early 2026, when the Consolidated Appropriations Act was signed into law, the PAMA data-collection period changed. It is now from Jan. 1, 2025, through June 30, 2025.
Reports must be submitted between May 1 and July 31, 2026. Submitting early will allow CMS to review your data and contact you if there are issues.
Note: See slides from AMP's March 2026 webinar for additional guidance.
Use the CLFS Data Collection Module within the Fee-for-Service Data Collection System (FFSDCS) accessed via the CMS Enterprise Portal.
Download a guide for registering with the portal.
Make sure you understand which two employees should do the reporting.
CMS has the authority to issue civil money penalties — up to $10,000 per day (adjusted for inflation) for each failure to report or each such misrepresentation or omission.
The weighted median will be the determined payment rate for 2027–2029.
On March 24, AMP held a webinar with essential updates on PAMA. It is now available for on-demand viewing. Watch to learn what regulatory changes have been implemented since the last reporting period, how they affect your organization, and what you need to report before May 1.
Download the presentation (PDF).
Speakers
Eric Konnick, M.D., M.S.
University of Washington Medical Center
Chair, AMP Professional Relations Committee
Jay Patel, M.D., MBA
ARUP Laboratories
Chair, AMP Economic Affairs Committee
Panelists
Vicky Pratt, Ph.D.
Agena Biosciences
Former AMP president
Clarisa Blattner, CCS CPC
XIFIN Inc.
AMP Economic Affairs Committee member
The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act is a sustainable, long-term solution to the issues caused by PAMA.